Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Tramadol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hip Fractures
1 trial -
Tranexamic Acid 100Mg/Ml Inj Vil 10Ml
Hospital Authority, Hong Kong
Rotator Cuff Tears
1 trial -
Tranexamic acid (TXA)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Blood Loss
1 trial -
Transdermal nicotine patch
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
Transesophageal echocardiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Critically Ill
1 trial -
Treatment
United Therapeutics Europe Ltd
Glucose Metabolism Disorders
1 trial -
Triferdine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Pregnancy Related
1 trial -
Trolamine (Biafine)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Dermatitis
1 trial -
Tumor Specific Antigen-loaded Dendritic Cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tumor Gastric
1 trial -
Tumour Biopsy and Venous Blood Tests
United Therapeutics Europe Ltd
Soft Tissue Sarcoma
1 trial -
UC-MSCs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
2019 Novel Coronavirus Pneumonia
1 trial -
UE
The First People's Hospital of Lianyungang
Lung Cancer
1 trial -
UMULINE NPH
Takeda
Type 2 Diabetes
1 trial -
Ublituximab
TG THERAPEUTICS, INC.
Multiple Sclerosis (MS) - Relapsing-remitting
1 trial -
Ulinastatin
The First People's Hospital of Lianyungang
Acute Respiratory Distress Syndrome
1 trial -
Ulinastatin and Thymosin Ξ±1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aortic Dissection
1 trial -
Ultra low dose chest computed tomography (ULDCT)
Hospital Authority, Hong Kong
Tuberculosis, Pulmonary
1 trial -
Ultrasound Elastography
Jazz Pharmaceuticals Ireland Limited
Bone Marrow Transplant Complications
1 trial -
Umbilical cord serum eyedrops
Hospital Authority, Hong Kong
Recurrent Corneal Erosion
1 trial -
Umooze
Biotech Pharmaceutical Co.,
Benign Prostatic Hyperplasia
1 trial -
Unfractionated heparin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary PCI
1 trial -
Urapidil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aging
1 trial -
Urinary EDC metabolite testing
Marker Therapeutics
Obesity &Amp;Amp;Amp; Overweight
1 trial -
Urinary EDC metabolite testing
Marker Therapeutics
Environmental Exposure
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources